Thursday, May 9, 2024

Register Now for Our May Joint Hubs Session with ARPANET-H Division Director

The Investor Catalyst Hub and Customer Experience Hub are excited to host a joint members-only meeting on Wednesday, May 15, 3:00-4:00 p.m. ET, to answer all your questions about ARPA-H’s growing health innovation network. ARPANET-H Division Director Amy Lin will provide an overview of the hub and spoke network, its capabilities and benefits, and how it can help transformative innovations reach both the market and the end-user. Don’t miss this essential ARPANET-H 101 session!

Save the Date for the Investor Catalyst Hub May Member Meeting

Register now to join the Investor Catalyst Hub’s members-only meeting on Thursday, May 30, at 2:00 p.m. ET. During this meeting, attendees will have the chance to hear from a panel of investor and venture capital spoke organizations and participate in a Q&A session. More details will be shared soon!

Submit Your HEROES Solution Summary

ARPA-H’s HEROES program is now accepting Solution Summary applications for a novel, regionally focused, outcomes-driven financing approach that incentivizes positive health outcomes and alleviates the substantial healthcare burden on patients, providers, and the broader economy.

The program is centered around four key outcome categories:

• Maternal health challenges
• Cardiovascular disease and risks
• Opioid overdose
• Alcohol-related health harms

Solution Summaries are due by June 28, 2024, and all interested parties with different specialties and areas of expertise are encouraged to apply! Visit the HEROES program web page to find more information, including solicitation details, upcoming webinars, and office hours.

Save Your Spot: LIGHT’s Hybrid Proposers’ Day

At last month’s member meeting, ARPA-H Program Manager Kimberley Steele, M.D., Ph.D., announced her new Lymphatic Imaging, Genomics, and pHenotyping Technologies (LIGHT) program, which will pursue comprehensive diagnostic tools and revolutionize the detection of lymphatic dysfunction. Log in to the member portal to view a recording of the meeting! Registration is now open for LIGHT’s hybrid Proposers’ Day, to be held on Tuesday, May 21, in Philadelphia, Pennsylvania, and online.

The Latest

• ARPA-H Director Dr. Renee Wegrzyn will visit Imperial College London for a conversation on high-risk, high-reward innovation and the importance of international research cooperation to amplify these efforts on Wednesday, May 15 at 1:00 p.m. ET / 10:00 a.m. PT. Reserve your spot by May 10 to watch via live stream or attend in person.
• While we continue to meet with spokes virtually, we’re also excited to offer in-person office hours at our office in Cambridge, Massachusetts. Contact us to schedule a time.
• IC Hub team members will be on site at the BIO conference June 3-6 in San Diego. We’d love to say hi—let us know if you’re attending!
• Help us reach all 50 states! If you know of an innovative organization in Alaska, Maine, or Oregon, please send us their name or encourage them to submit a spoke application.
• ARPA-H launched a new Exploration Topic to improve chatbots for patient-facing applications. Learn more.
• Have you made a connection with another spoke through an Investor Catalyst Hub–supported event, opportunity, or channel? Share your story!

Upcoming Spoke Events

Are you an official member with an upcoming event that would be of interest to the Investor Catalyst Hub network? Submit it today for publication consideration on our event calendar and in our upcoming newsletter! Take a look at these upcoming events from our member network:

Visit our website for a complete list of upcoming events.

 

Reminder: Upon application approval, all spokes receive an email to set up their account on the Investor Catalyst Hub member portal. If you haven’t activated your account, please do so as soon as possible to ensure you don’t miss any member-only communications, recordings, or important updates. Please contact us with any questions.

 

To stay up to date with the latest ARPA-H News, subscribe to ARPA-H Vitals.